Allulose and blood sugar

What 7 graded rows on allulose agree on for blood sugar, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Allulose page, with its PubMed record.

Your question

Supplement

Allulose and blood sugar

7 rows · 1,298 people

Mostly an improvement: 6 of 7 rows, and most of the people. 1 found no difference.

No difference
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade B× 1
  • Grade C× 1
  • Grade D× 4
  • No effect× 1
Rows
7
Trials
25
People
1,298
Pooled reviews may count some twice

Where they differ

From the rows
Study design

The best-graded row, grade B, is a meta-analysis of 1,033 people (2026) and found an improvement. 1 row is graded No effect, our grade for adequately powered trials that found no effect.

Only the 6 rows that found an improvement include pooled reviews of several trials (2 of 6); the row that found no difference is a single study.

The rows

6 improved · 1 no difference
  1. Grade BAfter-meal glucose and insulin (pooled trials) · Improved

    Meta-analysis, 12 studies · n 1,033 · 2026 · Adults in 20 controlled trials (12 of allulose, 8 of tagatose); 1,033 participants across both sugars, the allulose-only total is not given in the abstract

    As tested in the pooled trials (not stated in the abstract) · Single doses and longer trials

    Allulose lowered the after-meal glucose rise (incremental AUC SMD −0.66; 95% CI −0.92 to −0.39) and insulin (SMD −1.27; −2.14 to −0.40; I² 96%), both moderate certainty.

    Row on the Allulose page · PubMed 41985675 (opens PubMed)

  2. Grade CAfter-meal blood glucose in healthy people · Improved

    Meta-analysis, 8 studies · n 145 · 2023 · Healthy people in 8 small randomised crossover experiments (8 to 30 per group; 145 per group in total)

    5 g, or up to 10 g, with a meal · Single doses

    Incremental 2-hour glucose AUC was lower with 5 g (SMD −0.28; 95% CI −0.51 to −0.05) and with up to 10 g (SMD −0.26; −0.49 to −0.03), both rated moderate certainty.

    Row on the Allulose page · PubMed 37023000 (opens PubMed)

  3. Grade DGlucose and insulin after a sugar drink · Improved

    Crossover RCT · n 30 · 2021 · 30 people without diabetes

    2.5, 5, 7.5 or 10 g, single doses (vs placebo) · Single test days, 7 to 14 days apart

    Glucose at 30 minutes was lower with 7.5 g (mean difference 11; 95% CI 3 to 19) and 10 g (12; 4 to 20); overall glucose and insulin excursions fell significantly only with 10 g.

    Row on the Allulose page · PubMed 33637605 (opens PubMed)

  4. Grade DAfter-meal glucose in borderline diabetes, and 12-week safety · Improved

    Crossover RCT · n 26 · 2010 · 26 adults including people with borderline diabetes (crossover), plus 17 healthy adults in a 12-week safety arm

    5 g with a meal; 5 g three times a day in the safety arm · Single meals; 12 weeks for safety

    Glucose was lower 30 and 60 minutes after the meal (p<0.01, p<0.05) with a smaller AUC, mainly in borderline diabetes; 12 weeks of 15 g/day caused no abnormal effects or clinical problems.

    Row on the Allulose page · PubMed 20208358 (opens PubMed)

  5. Grade DPeak after-meal glucose on a diabetic diet in type 2 diabetes · Improved

    Crossover RCT · n 24 · 2023 · 24 hospital inpatients with type 2 diabetes in Japan (full text)

    8.5 g of allulose in the diet · 2 days on each diet, at least 1-day washout (full text)

    Peak after-meal glucose, measured by continuous glucose monitor, was lower on the allulose diet than on the standard energy-controlled diabetic diet; C-peptide fell, which the authors read as a lower insulin requirement.

    Row on the Allulose page · PubMed 37375710 (opens PubMed)

  6. Grade DGlucose after a glucose drink in type 2 diabetes · Improved

    Crossover RCT · n 24 · 2018 · 24 adults with type 2 diabetes in Toronto

    5 g or 10 g, single doses · Single test days, more than 1 week apart

    10 g lowered the glucose incremental AUC by 8% vs 0 g (717.4 vs 777.5 mmol×min/L, P = 0.015) with a linear dose response; fructose had no effect.

    Row on the Allulose page · PubMed 29797503 (opens PubMed)

  7. No effectGlucose control in type 2 diabetes · No difference

    Crossover RCT · n 16 · 2023 · 16 patients with type 2 diabetes (Thai trial)

    7 g twice daily (14 g/day) · 12 weeks per arm with a 2-week washout

    No significant effect on glucose tolerance, incretin levels or body composition; during allulose, HDL cholesterol fell from 51 to 41 mg/dL and MCP-1 rose from 259 to 297 pg/mL.

    Row on the Allulose page · PubMed 37432472 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.